ATG5 and cardiac hypertrophy: In line with the findings of Nakai et al., reporting that cardiac-specific deletion of Atg5 resulted in left ventricular dilatation, cardiac hypertrophy and contractile dysfunction in the heart [5], we demonstrated that Atg5 silencing directly impaired cardiomyocyte contractility.